Intravitreal aflibercept for macular edema following branch retinal vein occlusion: The 24-week results of the VIBRANT study

Ophthalmology

Volumn 122, Issue 3, 2015, Pages 538-544

  Campochiaro, Peter A ^a   Clark, W Lloyd ^b   Boyer, David S ^c   Heier, Jeffrey S ^d   Brown, David M ^e   Vitti, Robert ^f   Kazmi, Husain ^f   Berliner, Alyson J ^f   Erickson, Kristine ^f   Chu, Karen W ^f   Soo, Yuhwen ^f   Cheng, Yenchieh ^f   Haller, Julia A ^g  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Palmetto Retina Center   (United States)

^c RETINA VITREOUS ASSOCIATES MEDICAL GROUP   (United States)

^d OPHTHALMIC CONSULTANTS OF BOSTON   (United States)

^e HOUSTON METHODIST HOSPITAL   (United States)

^f REGENERON PHARMACEUTICALS INC   (United States)

^g WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; HYBRID PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR; VEGFA PROTEIN, HUMAN;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BEST CORRECTED VISUAL ACUITY; BRANCH RETINAL VEIN OCCLUSION; CENTRAL RETINAL THICKNESS; COMPARATIVE STUDY; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DEHYDRATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENDOPHTHALMITIS; EYE PAIN; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; LASER COAGULATION; LONG TERM CARE; MACULAR EDEMA; MACULAR GRID LASER PHOTOCOAGULATION; MAJOR CLINICAL STUDY; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; RADIATION INJURY; RADIOGRAPHIC GRID; RANDOMIZED CONTROLLED TRIAL; RETINA NEOVASCULARIZATION; RHINOPHARYNGITIS; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; TRAUMATIC CATARACT; VISUAL ACUITY; VISUAL IMPAIRMENT; AGED; ANTAGONISTS AND INHIBITORS; CLINICAL TRIAL; COMPLICATION; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUESTIONNAIRE; RETINAL VEIN OCCLUSION; SICKNESS IMPACT PROFILE;

AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INTRAVITREAL INJECTIONS; LASER COAGULATION; MACULAR EDEMA; MALE; MIDDLE AGED; QUESTIONNAIRES; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETINAL VEIN OCCLUSION; SICKNESS IMPACT PROFILE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 84924054198     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2014.08.031     Document Type: Article

References (25)

1. R.D. Sperduto, R. Hiller, and E. Chew Risk factors for hemiretinal vein occlusion: comparison with risk factors for central and branch retinal vein occlusion: the Eye Disease Case-Control Study Ophthalmology 105 1998 765 771
2. R. Klein, S.E. Moss, S.M. Meuer, and B.E. Klein The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study Arch Ophthalmol 126 2008 513 518
3. P. Mitchell, W. Smith, and A. Chang Prevalence and associations of retinal vein occlusion in Australia. The Blue Mountains Eye Study Arch Ophthalmol 114 1996 1243 1247
4. P.A. Campochiaro, G. Hafiz, and S.M. Shah Ranibizumab for macular edema due to retinal vein occlusions; implication of VEGF as a critical stimulator Mol Ther 16 2008 791 799
5. P.A. Campochiaro, R.B. Bhistikul, H. Shapiro, and R.G. Rubio Vascular endothelial growth factor promotes progressive retinal nonperfusion in patients with retinal vein occlusion Ophthalmology 120 2013 795 802
6. D.M. Brown, P.A. Campochiaro, R.P. Singh CRUISE Investigators Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study Ophthalmology 117 2010 1124 1133
7. P.A. Campochiaro, D.M. Brown, and C.C. Awh Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study Ophthalmology 118 2011 2041 2049
8. R.A. Costa, L.A. Jorge, and D. Calucci Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions IBeVO Study Retina 27 2007 141 149
9. K. Kriechbaum, S. Michels, and F. Prager Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study Br J Ophthalmol 92 2008 518 522
10. D. Boyer, J. Heier, and D.M. Brown Vascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS Study Ophthalmology 119 2012 1024 1032
11. F.G. Holz, J. Roider, and Y. Ogura VEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO study Br J Ophthalmol 97 2013 278 284
12. D.M. Brown, J.S. Heier, and W.L. Clark Intravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS study Am J Ophthalmol 155 2013 429 437
13. J. Holash, S. Davis, and N. Papadoupoulos VEGF-Trap: a VEGF blocker with potent antitumor effects Proc Natl Acad Sci U S A 99 2002 11393 11398
14. N. Papadopoulos, J. Martin, and Q. Ruan Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab Angiogenesis 15 2012 171 185
15. M.W. Stewart, and P.J. Rosenfeld Predicted biological activity of intravitreal VEGF Trap Br J Ophthalmol 92 2008 667 668
16. P. Carmeliet, L. Moons, and A. Luttun Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions Nat Med 7 2001 575 583
17. Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 1984 271 282
18. P.A. Campochiaro, J.S. Heier, L. Feiner BRAVO Investigators Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary endpoint results of a phase III study Ophthalmology 117 2010 1102 1112
19. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1 Arch Ophthalmol 103 1985 1796 1806
20. SCORE Study Research Group A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6 Arch Ophthalmol 127 2009 1115 1128
21. C. Pournaras, M. Tsacopoulos, and K. Strommer Experimental retinal branch vein occlusion in miniature pigs induces local tissue hypoxia and vasoproliferative microangiopathy Ophthalmology 97 1990 1321 1328
22. C.J. Pournaras, M. Tsacopoulos, and K. Strommer Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs Ophthalmology 97 1990 1329 1333
23. Q.D. Nguyen, S.M. Shah, and E. Van Anden Supplemental oxygen improves diabetic macular edema: a pilot study Invest Ophthalmol Vis Sci 45 2003 617 624
24. D.M. Brown, P.A. Campochiaro, and R.B. Bhisitkul Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study Ophthalmology 118 2011 1594 1602
25. J.A. Haller, F. Bandello, R. Belfort Jr. Ozurdex GENEVA Study Group Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results Ophthalmology 118 2011 2453 2460